Anti-SEM3F/ SEMA3F/ SEMA-IV functional antibody

Anti-SEM3F/ SEMA3F/ SEMA-IV functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SEMA3F/SEMA3F products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1273-Ab-1/ GM-Tg-hg-SE1273-Ab-2Anti-Human SEMA3F monoclonal antibodyHuman
GM-Tg-rg-SE1273-Ab-1/ GM-Tg-rg-SE1273-Ab-2Anti-Rat SEMA3F monoclonal antibodyRat
GM-Tg-mg-SE1273-Ab-1/ GM-Tg-mg-SE1273-Ab-2Anti-Mouse SEMA3F monoclonal antibodyMouse
GM-Tg-cynog-SE1273-Ab-1/ GM-Tg-cynog-SE1273-Ab-2Anti-Cynomolgus/ Rhesus macaque SEMA3F monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1273-Ab-1/ GM-Tg-felg-SE1273-Ab-2Anti-Feline SEMA3F monoclonal antibodyFeline
GM-Tg-cang-SE1273-Ab-1/ GM-Tg-cang-SE1273-Ab-2Anti-Canine SEMA3F monoclonal antibodyCanine
GM-Tg-bovg-SE1273-Ab-1/ GM-Tg-bovg-SE1273-Ab-2Anti-Bovine SEMA3F monoclonal antibodyBovine
GM-Tg-equg-SE1273-Ab-1/ GM-Tg-equg-SE1273-Ab-2Anti-Equine SEMA3F monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1273-Ab-1/ GM-Tg-hg-SE1273-Ab-2; GM-Tg-rg-SE1273-Ab-1/ GM-Tg-rg-SE1273-Ab-2;
GM-Tg-mg-SE1273-Ab-1/ GM-Tg-mg-SE1273-Ab-2; GM-Tg-cynog-SE1273-Ab-1/ GM-Tg-cynog-SE1273-Ab-2;
GM-Tg-felg-SE1273-Ab-1/ GM-Tg-felg-SE1273-Ab-2; GM-Tg-cang-SE1273-Ab-1/ GM-Tg-cang-SE1273-Ab-2;
GM-Tg-bovg-SE1273-Ab-1/ GM-Tg-bovg-SE1273-Ab-2; GM-Tg-equg-SE1273-Ab-1/ GM-Tg-equg-SE1273-Ab-2
Products NameAnti-SEMA3F monoclonal antibody
Formatmab
Target NameSEMA3F
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SEMA3F benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1273-Ag-1Recombinant multi-species SEM3F/ SEMA3F/ SEMA-IV protein


    Target information

    Target IDGM-SE1273
    Target NameSEMA3F
    Gene ID6405,20350,315996,703995,484763,101091515,531141,100062215
    Gene Symbol and SynonymsSEMA-IV,SEMA3F,SEMA4,SemaIV,SEMAK
    Uniprot AccessionQ13275
    Uniprot Entry NameSEM3F_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000001617
    Target ClassificationN/A

    The target: SEMA3F, gene name: SEMA3F, also named as SEMA-IV, SEMA4, SEMAK. This gene encodes a member of the semaphorin III family of secreted signaling proteins that are involved in axon guidance during neuronal development. The encoded protein contains an N-terminal Sema domain, an immunoglobulin loop and a C-terminal basic domain. This gene is expressed by the endothelial cells where it was found to act in an autocrine fashion to induce apoptosis, inhibit cell proliferation and survival, and function as an anti-tumorigenic agent. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.